Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies (ADPT) Financial Statements


Adaptive Biotechnologies Financial Overview

Adaptive Biotechnologies's market cap is currently ―. The company's EPS TTM is $-1.33; its P/E ratio is -4.10; Adaptive Biotechnologies is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 48.93M$ 37.65M$ 55.20M$ 47.83M$ 43.66M
Gross Profit$ 31.02M$ 18.97M$ 38.61M$ 32.92M$ 30.44M
EBIT$ -44.21M$ -54.17M$ -39.19M$ -44.67M$ -52.50M
EBITDA$ -40.47M$ -50.35M-$ -39.28M$ -47.31M
Net Income Common Stockholders$ -47.81M$ -57.70M$ -40.13M$ -45.28M$ -52.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 417.23M$ 440.69M$ 498.20M$ 508.08M$ 383.74M
Total Assets$ 764.52M$ 791.46M$ 773.17M$ 884.21M$ 806.63M
Total Debt$ 103.52M$ 105.78M$ 108.00M$ 109.05M$ 111.34M
Net Debt$ -313.71M$ -334.91M$ -390.19M$ -399.03M$ -272.40M
Total Liabilities$ 368.57M$ 367.51M$ 856.62M$ 396.39M$ 288.32M
Stockholders Equity$ 396.04M$ 424.02M$ 464.17M$ 487.84M$ 518.30M
Cash Flow-
Free Cash Flow$ -27.25M$ -62.08M$ -32.58M$ -47.84M$ -52.36M
Operating Cash Flow$ -23.56M$ -59.15M$ -30.04M$ -42.41M$ -47.06M
Investing Cash Flow$ 37.32M$ 62.98M$ -97.54M$ 58.02M$ 4.75M
Financing Cash Flow$ 1.47M$ 672.00K$ 6.00K$ 125.52M$ 3.99M
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

Adaptive Biotechnologies Debt to Assets

Adaptive Biotechnologies Cash Flow

Adaptive Biotechnologies Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis